The third edition of the ewimed report was produced by ewimed for the first time in a transnational collaboration. This international focus means that the topic of “Treatment options for pleural effusion and ascites” is also viewed from other perspectives and shows that the subcutaneously tunneled pleural and/or peritoneal indwelling catheter is used internationally for this treatment.
Folgende Themen erwarten Sie:
5-Jahres Verlauf (2019-2023) der Daten des ewimed Patientenfragebogens
2 ausführliche Zusammenfassungen aus unserer Sicht sehr relevanter Studien für Pleuraerguss und Aszites
Lebensqualität bei Patienten mit subkutan getunneltem Pleura/oder Peritoneal-
verweilkatheter aus Sicht eines Arztes aus Wien und eines Patienten aus Schweden
Einsatz eines subkutan getunnelten Pleura/oder Peritoneal-
verweilkatheter bei fortlaufender Chemotherapie diskutiert mit einem Arzt aus der Schweiz
Einige kurze Ausblicke in europäische Gesundheitsmärkte und deren Herausforderungen
The ewimed Report 2024 publishes the current data from the 2023 data collection of the internal ewimed patient questionnaire. This has been recorded and evaluated for 14 years for all ewimed patients throughout Germany. In addition, the literature on pleural effusion and ascites that ewimed considers relevant in 2023 is summarized. The topic of quality of life in patients with IPC is discussed in the chapter of the same name both from a medical perspective by Prof. Dr. Clemens Aigner from the University Hospital/Vienna General Hospital in Austria and from a patient perspective by one of our Swedish patients. Another chapter of this year’s ewimed report is the topic of IPC during ongoing chemotherapy. Here you will find an interesting interview with oncologist Dr. Yannick Buccella from Zurich City Hospital in Switzerland, as well as the possibilities and advantages of IPC during chemotherapy. Finally, you will find an overview of the current situation and upcoming changes in the healthcare markets in some of our European locations.
Mit dem Laden des Videos akzeptieren Sie die Datenschutzerklärung von YouTube.
Mehr erfahren
